A phase I study of intravenous TZT-1027 administered on day 1 and day 8 of a three-weekly cycle in combination with carboplatin given on day 1 alone in patients with advanced solid tumoursAlastair Greystoke, William P. Steward, Sarah P. Blagden et al.|Annals of Oncology|2006Cited by 24
Phase I study of ispinesib (SB-715992) in combination with docetaxel in patients with advanced solid tumors.Sarah P. Blagden, Mark R. Middleton, Alison Reid et al.|Clinical Cancer Research|2005Cited by 1